Retinoids, breast cancer and NK cells

A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Takashi Uchiyama, S Broder, Thomas A. Waldmann · The Journal of Immunology · 1981 · 1.3K citations · Full text

Life Sciences, Cell Biology, Immunology +16

Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.

Franca Formelli, Roberto Carsana, A. Costa et al. · PubMed · 1989 · 140 citations

Medicine, Oncology, Pharmacology +7

Long-term tolerability of fenretinide (4-HPR) in breast cancer patients

Nicole Rotmensz, G. De Palo, Franca Formelli et al. · European Journal of Cancer and Clinical Oncology · 1991 · 115 citations

Medicine, Oncology, Pharmacology +12

Pharmacokinetics of n‐4‐hydroxyphenyl‐retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients

Yei‐Mei Peng, William S. Dalton, David S. Alberts et al. · International Journal of Cancer · 1989 · 61 citations

Medicine, Pharmacokinetics, Pharmacology +10

N-(4-hydroxyphenyl)-all-trans-retinamide pharmacokinetics in female rats and mice.

T A Hultin, C M May, R C Moon · Drug Metabolism and Disposition · 1986 · 53 citations

Medicine, Pharmacokinetics, Pharmacology +12